GlassScriptPhysician profile
Sherry Jose
NPI 1922006600
$8,832.03
in general payments reported to CMS, 2019-2025
37 companies · $2,745 in 2025
The $2,745 reported for 2025 was more than what 87% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.58 · 2020: $272 · 2021: $1,043 · 2022: $1,427 · 2023: $1,235 · 2024: $2,095 · 2025: $2,745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,731 · Travel and Lodging: $1,319 · Education: $24.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,731.31 |
| Travel and Lodging | $1,319.22 |
| Education | $24.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,393.05 | 2020-2025 | Wavewriter Alpha Prime 16, General - Therapies |
| Spinal Simplicity, LLC | $1,115.13 | 2025 | Ha Minuteman G3-R, Patriot Si |
| Abbott Laboratories | $1,056.48 | 2021-2025 | Proclaim, Infinity, Eterna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $978.72 | 2020-2025 | Relistor, Trulance |
| Collegium Pharmaceutical, INC. | $653.68 | 2021-2025 | Xtampza, Belbuca |
| Nalu Medical, INC. | $567.65 | 2021-2024 | Nalu Neurostimulation System |
| Scilex Pharmaceuticals INC. | $488.37 | 2019-2025 | Ztlido |
| Nevro Corp. | $422.48 | 2020-2024 | Senza |
| Globus Medical, INC. | $236.46 | 2025 | Senza |
| Forte Bio-Pharma LLC | $204.70 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Grt US Holding, INC. | $184.03 | 2021-2022 | |
| Averitas Pharma INC. | $160.48 | 2025 | Qutenza |
| Protega Pharmaceutials INC | $142.80 | 2023 | Roxybond |
| Spr Therapeutics, INC | $109.76 | 2022 | |
| Curonix LLC | $107.22 | 2022-2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $101.30 | 2023 | Comprehensive |
| Biodelivery Sciences International, INC. | $99.24 | 2020-2021 | |
| Lilly USA, LLC | $98.27 | 2022 | |
| Si-Bone, INC. | $91.85 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $78.20 | 2024-2025 | |
| Medtronic, INC. | $76.31 | 2021-2025 | Intellis Adaptivestim |
| Biotronik Nro, INC. | $68.80 | 2025 | Prospera |
| Almatica Pharma LLC | $44.80 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $39.77 | 2021 | |
| Mindray Ds USA, INC. | $39.56 | 2023 | A7 Anesthesia System |
| Valinor Pharma, LLC | $35.77 | 2024-2025 | Movantik |
| Stimwave Technologies Incorporated | $31.36 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.22 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $25.24 | 2023 | Zilretta, Iovera |
| Fidia Pharma USA INC. | $23.06 | 2022 | |
| Biogen, INC. | $22.25 | 2021 | |
| Vertos Medical, INC. | $21.29 | 2024 | Mild Device Kit |
| Foundation Fusion Solutions, LLC | $21.24 | 2025 | |
| Pfizer INC. | $21.22 | 2024 | |
| Alkermes, INC. | $18.52 | 2025 | Vivitrol |
| Electronic Waveform Lab, INC. | $13.80 | 2020 | |
| Zyla Life Sciences, INC. | $12.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherry Jose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.